Work

A multicenter, double-blind, placebo-controlled randomized phase II trial of gemcitabine/cisplatin (GC) plus bevacizumab (B) or placebo in patients (pts) with malignant mesothelioma (MM)

Year: 2005

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2005.23.16_suppl.7019

Authors: H. L. Kindler, T. Karrison, C. Lu, D. R. Gandara, J. Stevenson, L. Krug, P. Janne, T. L. Guterz, W. M. Stadler, E. E. Vokes

Institutions: University of Chicago, Dana-Farber Cancer Institute, University of Pennsylvania, University of California, Davis

Language: English

Topic: Occupational and environmental lung diseases

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4252360359

Cites:

Cited by: 10

Related to: 10